MRFF
- Competitive funding process remains on foot
- Early 2021 announcement for successful bids
FDA
- 513(g) RFI submitted as previously noted- Purpose: seek FDA guidance on what product classification would be most appropriate for EMV's Gen 2 portable brain scanner device and what appropriate regulatory pathway will be
- In dialogue with FDA
- FDA aware response is overdue
- Anticipate response no later than early 2021
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.81 |
Change
0.075(4.34%) |
Mkt cap ! $154.3M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.81 | $1.75 | $77.20K | 43.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2890 | $1.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 5857 | 1 |
View Market Depth
| Last trade - 15.47pm 25/07/2025 (20 minute delay) ? |
| EMV (ASX) Chart |